Article Details
Retrieved on: 2024-01-06 02:31:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Intas Pharmaceuticals plans to commercialize DMB-3115 through Accord BioPharma (US), Accord Healthcare (EU, UK, and Canada), and other subsidiaries ...
Article found on: www.valdostadailytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here